Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2007
06/06/2007EP1402034B1 Identification of ses-1 and the uses of the same
06/06/2007EP1392254B1 Micellar drug delivery systems for hydrophobic drugs
06/06/2007EP1381431B1 Aromatase inhibition to enhance implantation rate
06/06/2007EP1378267B1 Use of flumazenil to produce a medicament for the treatment of cocaine dependency
06/06/2007EP1363874B1 Tryptase inhibitors
06/06/2007EP1363601B1 Amphoteric liposomes and the use thereof
06/06/2007EP1354046B1 Regulation of expression of eer-7, a member of the lysyl oxidase gene family, by estrogen receptors
06/06/2007EP1289556B1 Isoflavones against radiation-induced mortality
06/06/2007EP1283699B1 Injectable suspensions having improved injectability properties
06/06/2007EP1229922B1 Aplidine treatment of cancers
06/06/2007EP1158958B1 Improved powdery pharmaceutical compositions for inhalation
06/06/2007EP0956017B1 Benzimidazole-2-carbamates for the treatment of viral infections and cancer
06/06/2007EP0954317B1 Use of 7 apha-substituted steroids to treat neuropsychiatric disorders
06/06/2007EP0886679B1 Parapoxviruses containing foreign dna, their production and their use in vaccines
06/06/2007EP0862625B1 Methods for modulation of cholesterol transport
06/06/2007EP0839039B2 Paroxetine controlled release compositions
06/06/2007DE10335634B4 Verwendung von Perilla-, Geranium- und Citronellsäure sowie ausgewählten Derivaten zur Konservierung, zur Behandlung von Akne, Schuppen oder Dematomykosen sowie zur Bekämpfung Körpergeruch verursachender Mikroorganismen Use of perilla, geranium and citronellic acid derivatives and selected for preservation, for the treatment of acne, dandruff or Dematomykosen and to combat body odor-causing microorganisms
06/06/2007DE102005058166A1 Matrixkontrolliertes transdermales System mit Amin-Salzen der ACE-Hemmer-Dicarbonsäuren Controlled matrix transdermal system with amine salts of the ACE inhibitor dicarboxylic acids
06/06/2007DE102005057924A1 Pyridazinonderivate Pyridazinone derivatives
06/06/2007DE102005052174A1 Phenylen-bis-oxazolidin-Derivate und ihre Verwendung Phenylene-bis-oxazolidine derivatives and their use
06/06/2007DE102005050498A1 Cyclopropylessigsäure-Derivate und ihre Verwendung Cyclopropylacetic acid derivatives and their use
06/06/2007DE102004062182B4 Transdermales Pflaster mit Progesteron A-Spezifische Liganden (PRASL) als Wirkstoff Transdermal patch with progesterone A-specific ligands (PRASL) as active ingredient
06/06/2007CN1977052A Method for diagnosing non-small cell lung cancer
06/06/2007CN1977044A Compositions and methods for treating pancreatic cancer
06/06/2007CN1976944A 雌激素受体调节剂 Estrogen receptor modulators
06/06/2007CN1976938A Thienopyrazole derivative having PDE7 inhibitory activity
06/06/2007CN1976937A The extract of bulbophgllum radiatum lindl and the preparation and the use
06/06/2007CN1976936A Tetrahydroquinolines
06/06/2007CN1976935A Pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists
06/06/2007CN1976934A Alkyl substituted indoloquinoxalines
06/06/2007CN1976932A Fused quinoline derivative and use thereof
06/06/2007CN1976931A Beta-carbolines useful for treating inflammatory disease
06/06/2007CN1976930A 6,7,8,9-substituted 1-phenyl-1,5-dihydro-pyrido(3,2-b)indol-2-ones useful as anti-infective pharmaceutical agents
06/06/2007CN1976929A 咪唑并吡啶化合物 Imidazopyridine compound
06/06/2007CN1976928A Indolylalkylamine metabolites as 5-hydroxytryptamine-6 ligands
06/06/2007CN1976927A Quinoline thiazolinone compound
06/06/2007CN1976925A Prodrugs of pyrrolylpyrimidine ERK protein kinase inhibitors
06/06/2007CN1976924A Crystalline forms of a pyridinyl-sulfonamide and their use as endothelin receptor antagonists
06/06/2007CN1976923A Solid forms of the magnesium salt of (s)-omeprazole and processes for their preparation
06/06/2007CN1976921A Crystal forms of (3R)-1-(2-methylalanyl-D-tryptophyl)-3-(phenylmethyl)-3-piperidinecarboxylic acid 1,2,2-trimethylhydrazide
06/06/2007CN1976920A N-type calcium channel blockers
06/06/2007CN1976919A Pyrrole inhibitors of ERK protein kinase, synthesis thereof and intermediates thereto
06/06/2007CN1976918A 4,5-disubstituted-2-aryl pyrimidines
06/06/2007CN1976917A Pyridine derivatives of alkyl oxindoles functioning as active substance against 5-HT7 receptor
06/06/2007CN1976916A Selected CGRP - antagonists, process for preparing them and their use as pharmaceutical compositions
06/06/2007CN1976915A Hiv整合酶抑制剂 Hiv integrase inhibitors
06/06/2007CN1976910A Novel 2,4-diaminothiazol-5-one derivatives
06/06/2007CN1976908A Method for preparing 5-[4-(2-hydroxy-ethyl)-3,5-dioxo-4,5-dihydro-3H-[1,2,4]-triazin-2-yl]benzamide derivatives with P 2 X 7 inhibiting activity by reaction of the derivative unsubstituted in 4-positi
06/06/2007CN1976906A Substituted 2-alkyl quinazolinone derivatives as PARP inhibitors
06/06/2007CN1976905A Pyrimidine derivatives and methods of treatment related to the use thereof
06/06/2007CN1976904A Pyridazin-3(2H)-one derivatives and their use as PDE4 inhibitors
06/06/2007CN1976903A Factor VóÄa inhibitor
06/06/2007CN1976902A N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
06/06/2007CN1976901A Novel arylamidine derivative, salt thereof, and antifungal containing these
06/06/2007CN1976748A Granules comprising a beta-lactam antibiotic
06/06/2007CN1976747A Product comprising a beta-lactam antibiotic
06/06/2007CN1976726A Compositions and methods for modulating bone mass
06/06/2007CN1976723A Treatment of infectious diseases
06/06/2007CN1976722A 活性物质联合 Active substances combined
06/06/2007CN1976712A Medical solution, method for producing and use thereof
06/06/2007CN1976711A Administration of cisplatin by inhalation
06/06/2007CN1976710A Compounds and compositions as cathepsin S inhibitors
06/06/2007CN1976709A Use of imatinib to treat liver disorders and viral infections
06/06/2007CN1976708A Combination comprising a BCRP inhibitor and 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyridimin-2-ylamino)phenyl]-benzamide
06/06/2007CN1976707A 3-aminocyclopentanecarboxamides as modulators of chemotactic factor receptors
06/06/2007CN1976706A Inhibition of FGFR3 and treatment of multiple myeloma
06/06/2007CN1976705A 1,1,1- trifluoro-4-phenyl-4-methyl-2-(1H-pyrrolo not 2,3-C|pyridin-2-ylmethyl)pentan-2-ol derivatives and related compounds as glucocorticoid ligands for the treatment of inflammatory diseases and dia
06/06/2007CN1976704A Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases
06/06/2007CN1976703A Method for increasing the susceptibility of peptide deformylase inhibitors by using efflux pump inhibitors
06/06/2007CN1976702A 3-aminocyclopentanecarboxamides as modulators of chemotactic factor receptors
06/06/2007CN1976701A 毒蕈碱性乙酰胆碱受体拮抗剂 Muscarinic acetylcholine receptor antagonist
06/06/2007CN1976700A Treatment of neuropathic pain, fibromyalgia or rheumatoid arthritis
06/06/2007CN1976699A Synthesis of epothilones, intermediates thereto, analogues and uses thereof
06/06/2007CN1976698A 2-methylthiazolidine-2,4-dicarboxylic acid-containing combination preparations
06/06/2007CN1976697A Liver function modifier
06/06/2007CN1976696A Pharmaceutical composition for prevention or treatment of lipid metabolism disorder
06/06/2007CN1976695A Compositions for urinary dysfunction and edema containing decursin and/or decursinol angelate, or angelica extract containing decursin and /or decursinol angelate
06/06/2007CN1976694A Topical formulations for treating allergic diseases
06/06/2007CN1976693A Transthyretin stabilization
06/06/2007CN1976692A Methods and compositions for treating ophthalmic conditions with retinyl derivates
06/06/2007CN1976691A Cysteamines for treating complications of hypercholesterolemia and diabetes
06/06/2007CN1976690A Pharmaceutical compositions for the treatment of disease and/or symptoms in arthritis
06/06/2007CN1976689A Topical methadone compositions and methods for using the same
06/06/2007CN1976685A Oral antimicrobial pharmceutical compositions
06/06/2007CN1976682A Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active component
06/06/2007CN1976679A Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
06/06/2007CN1976678A Manufacturing of quick release pharmaceutical compositions of water insoluble drugs and pharmaceutical compositions obtained by the process of the invention
06/06/2007CN1974603A Alpha-glucosan originated from ash tree flower sporophore and its prepn process and use
06/06/2007CN1974596A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
06/06/2007CN1974595A Amino butanetriol aescin and its prepn process
06/06/2007CN1974594A Human myocardial troponin I subunit nucleic acid adaptor and its application
06/06/2007CN1974591A SiRNA expression template for treating liver necrosis and liver fibrosis
06/06/2007CN1974576A N1,N8-disubstituent-triethyl tetramine copper (II) complex and its prepn process
06/06/2007CN1974574A Novel tricyclic spiropiperidines or spiropyrrolidines
06/06/2007CN1974570A Fused pyrrolocarbazoles against inflammation
06/06/2007CN1974569A 8-octyl berberine hydrochloride and its synthesis process and application
06/06/2007CN1974560A Compound 3-isopropyl-6-(2-methylbutyl) piperazine-2,5-dione and its prepn and application
06/06/2007CN1974558A (+)-Meptazinol diligand derivative and/or its salt and the prepn process
06/06/2007CN1974557A 5-arylamino quinolyl-7,8-dione derivative and its application in preparing antibiotic medicine
06/06/2007CN1974554A Cyclin imide peptidyl metalloprotease inhibitor and its application
1 ... 3725 3726 3727 3728 3729 3730 3731 3732 3733 3734 3735 3736 3737 3738 3739 3740 3741 3742 3743 3744 3745 ... 7860